Unitedhealth Group INC Form 4 insider transactions

Andrew Witty, CEO of UnitedHealth Group, reports acquisition of common stock through dividend equivalents and the Employee Stock Purchase Plan.

Thomas E. Roos, Chief Accounting Officer of UnitedHealth Group, reports acquiring and disposing of common stock on September 24, 2024, according to a Form 4 filing with the SEC.

Director Timothy Patrick Flynn reports acquisition of 31 shares of common stock and disposal of 2,000 shares held indirectly through a trust.

Valerie Montgomery Rice, a director at UnitedHealth Group, acquired 20 shares of common stock through dividend equivalents on vested deferred stock units.

Erin McSweeney, EVP & Chief People Officer at UnitedHealth Group, reports acquisition and disposal of common stock due to dividend equivalents on restricted stock units.

Stephen Hemsley, a director at UnitedHealth Group, reported the distribution of UNH shares from Grantor Retained Annuity Trusts and subsequent direct ownership changes.

Stephen J. Hemsley, a director at UnitedHealth Group, reported changes in his beneficial ownership of company stock due to gift conveyances and annuity payments.

Thomas E. Roos, Chief Accounting Officer of UnitedHealth Group, reported the sale of 2,851 shares of common stock at a weighted average price of $569.8822 and a gift of 439 shares.

Erin McSweeney, EVP & Chief People Officer of UnitedHealth Group, reported selling 1,500 shares of common stock at an average price of $579.0253 on July 18, 2024.

Paul R. Garcia, a director at UnitedHealth Group, reported a transaction involving the distribution of 30 UNH shares from a trust to its beneficiary on July 18, 2024.

Director Valerie Montgomery Rice acquired 190 shares of UnitedHealth Group common stock as part of her quarterly compensation for serving on the board.

Director Paul R. Garcia reports acquisition of UnitedHealth Group common stock and deferred stock units as part of regular quarterly compensation.

Director Kristen Gil reports acquisition of UnitedHealth Group common stock and deferred stock units as part of regular quarterly compensation.

Director Timothy Flynn reports acquiring 190 shares of UnitedHealth Group common stock as part of deferred stock units granted for board service.

John H. Noseworthy, a director at UnitedHealth Group, acquired 190 shares of common stock on July 1, 2024, as part of his director compensation.

Director Charles D. Baker reports acquisition of 177 deferred stock units of UnitedHealth Group as part of quarterly compensation.

Director Stephen J. Hemsley reports acquisition of deferred stock units and adjustments to beneficial ownership of UnitedHealth Group stock.

Director Frederick William McNabb III acquired 194 deferred stock units of UnitedHealth Group on July 1, 2024, as part of his quarterly compensation for board service.

Director Michele J. Hooper reports acquiring 114 deferred stock units of UnitedHealth Group as part of regular quarterly compensation.

Director Charles D. Baker reports acquiring 2 shares of UnitedHealth Group common stock due to dividend equivalents paid on vested deferred stock units.

Brian R. Thompson, CEO of UnitedHealthcare, reported changes in beneficial ownership of UnitedHealth Group stock, including the acquisition of dividend equivalents and disposal of common stock.

Frederick William McNabb III, a director at UnitedHealth Group, acquired 28 shares of common stock through dividend equivalents on vested deferred stock units.

Director Stephen J. Hemsley reports acquiring 28 shares of UnitedHealth Group common stock through dividend equivalents, according to a Form 4 filing.

EVP & Chief People Officer of UnitedHealth Group, Erin McSweeney, reports acquisition and disposal of common stock due to dividend equivalents on restricted stock units.

John H. Noseworthy, a director at UnitedHealth Group, acquired 22 shares of common stock through dividend equivalents on June 25, 2024.

John F. Rex, President & CFO of UnitedHealth Group, reports acquisition and disposal of common stock and dividend equivalents related to restricted stock units.

Thomas E. Roos, Chief Accounting Officer of UnitedHealth Group, reports acquisition of common stock due to dividend equivalents paid on restricted stock units.

Director Valerie Montgomery Rice acquired 22 shares of UnitedHealth Group common stock through dividend equivalents on vested deferred stock units.

Director Kristen Gil reports acquisition of common stock and dividend equivalents, and disposal of common stock.

Christopher R. Zaetta, EVP & Chief Legal Officer of UnitedHealth Group, reports acquisition of common stock due to dividend equivalents paid on restricted stock units.